BMI1 is a novel, preclinical target in fusion-positive rhabdomyosarcoma
1 of 10
Tumorigenic, oncogenic, and cell cycle effects of H2A/H3 oncohistone mutations explored through structural modeling and analysis in Saccharomyces cerevisiae
2 of 10
The Role of Metabolic Enzymes in Immunotherapy Resistance in Non-Small Cell Lung Cancer
3 of 10
Characterization of Jagged1-Notch signaling in collective invasion and determination of ALCAM expression in non-small cell lung cancer models
4 of 10
Reprogramming the Immune Phenotype of Rb-deficient Prostate Cancer Cells via BET Inhibition
5 of 10
Aurora Kinase A Promotes Oncogenic Signaling Through Novel Protein-Protein Interactions
6 of 10
Genetic analysis of Yorkie-driven overgrowth: depletion of transcriptional targets
7 of 10
Effects of Stable Insulin-like Growth Factor 1 Receptor Knockdown
on Triple-Negative Breast Cancer Cells
8 of 10
The Effect of Curcumin Analogues on
Metastasis
9 of 10
Investigation of the Long Non Coding RNA Growth Arrest Specific 5 Control of Cell Fate